These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8434651)

  • 1. CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells.
    Hany D; Vafeiadou V; Picard D
    Sci Adv; 2023 May; 9(19):eadd3685. PubMed ID: 37172090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer.
    Hany D; Zoetemelk M; Bhattacharya K; Nowak-Sliwinska P; Picard D
    Cell Mol Life Sci; 2023 Mar; 80(3):80. PubMed ID: 36869202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the
    Bousquet PA; Manna D; Sandvik JA; Arntzen MØ; Moreno E; Sandvig K; Krengel U
    Front Immunol; 2022; 13():994790. PubMed ID: 36439103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The five dimensions of B cell tolerance.
    Platt JL; Garcia de Mattos Barbosa M; Cascalho M
    Immunol Rev; 2019 Nov; 292(1):180-193. PubMed ID: 31609002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody.
    Leung SO; Gao K; Wang GY; Cheung BK; Lee KY; Zhao Q; Cheung WT; Wang JZ
    MAbs; 2015; 7(1):66-76. PubMed ID: 25427174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of Lewis(y) and Lewis(b) with a novel monoclonal antibody 692/29.
    Noble P; Spendlove I; Harding S; Parsons T; Durrant LG
    PLoS One; 2013; 8(2):e54892. PubMed ID: 23408949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lonely killers: effector cell- and complement-independent non-proapoptotic cytotoxic antibodies inducing membrane lesions.
    Fernández-Marrero Y; López-Requena A
    MAbs; 2011; 3(6):528-34. PubMed ID: 22123064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma Cells.
    Dobroff AS; Rodrigues EG; Juliano MA; Friaça DM; Nakayasu ES; Almeida IC; Mortara RA; Jacysyn JF; Amarante-Mendes GP; Magliani W; Conti S; Polonelli L; Travassos LR
    Transl Oncol; 2010 Aug; 3(4):204-17. PubMed ID: 20689762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.
    Silletti S; Paku S; Raz A
    Pathol Oncol Res; 1997 Sep; 3(3):230-54. PubMed ID: 18470736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis.
    Koch AE; Nickoloff BJ; Holgersson J; Seed B; Haines GK; Burrows JC; Leibovich SJ
    Am J Pathol; 1994 Feb; 144(2):244-59. PubMed ID: 8311112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake.
    Hurwitz E; Stancovski I; Sela M; Yarden Y
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3353-7. PubMed ID: 7724565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model.
    Marecos E; Weissleder R; Bogdanov A
    Bioconjug Chem; 1998; 9(2):184-91. PubMed ID: 9548533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membranes.
    Garrigues J; Anderson J; Hellström KE; Hellström I
    J Cell Biol; 1994 Apr; 125(1):129-42. PubMed ID: 7511141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unmodified anticarcinoma antibody, BR96, localizes to and inhibits the outgrowth of human tumors in nude mice.
    Schreiber GJ; Hellström KE; Hellström I
    Cancer Res; 1992 Jun; 52(12):3262-6. PubMed ID: 1596883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ley specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes.
    Garrigues J; Garrigues U; Hellström I; Hellström KE
    Am J Pathol; 1993 Feb; 142(2):607-22. PubMed ID: 8434651
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.